Showing results (1831-1840 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|June 12, 2012
Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trialMichel Baulac, Martin J Brodie, Anna Patten, et al.
The Lancet. Neurology|November 22, 2012
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trialVincent J J Odekerken, Teus van Laar, Michiel J Staal, et al.
The Lancet. Neurology|September 19, 2014
The neuro-ophthalmology of head traumaRachel E Ventura, Laura J Balcer, Steven L Galetta
The Lancet. Neurology|September 19, 2014
Epidemiology, causes, and treatment of epilepsy in sub-Saharan AfricaAwa Ba-Diop, Benoît Marin, Michel Druet-Cabanac, et al.
The Lancet. Neurology|August 4, 2014
Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies
The Lancet. Neurology|July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to careAngela C Hirbe, David H Gutmann
The Lancet. Neurology|December 3, 2013
The genetic basis of DOORS syndrome: an exome-sequencing studyPhilippe M Campeau, Dalia Kasperaviciute, James T Lu, et al.
The Lancet. Neurology|September 27, 2013
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trialMerit E Cudkowicz, Leonard H van den Berg, Jeremy M Shefner, et al.
The Lancet. Neurology|October 1, 2013
Combination pharmacotherapy for management of chronic pain: from bench to bedsideIan Gilron, Troels S Jensen, Anthony H Dickenson
The Lancet. Neurology|October 1, 2013
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trialMyron D Ginsberg, Yuko Y Palesch, Michael D Hill, et al.
Pageof 200